-
Mashup Score: 1Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies - 4 day(s) ago
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited, and there are a multitude of associated conditions with overlapping symptoms which can make the diagnosis and management of POTS a difficult experience for providers and patients alike.
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies - 15 day(s) ago
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited, and there are a multitude of associated conditions with overlapping symptoms which can make the diagnosis and management of POTS a difficult experience for providers and patients alike.
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
ACC.24 — Dr Andrew P DeFillipis (Vanderbilt University Medical Center, US) joins us onsite at ACC to discuss the findings from a subgroup analysis of the MINT Trial (NCT02981407).MINT is
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
NEW #ACC24 Featured Science Interview 💫Dr Andrew DeFilippis joins us to discuss findings from a subgroup analysis of the MINT Trial. 📽️👉 https://t.co/jTtJyekxb0 📊In pts with type 1 MI and anaemia 👉 a restrictive 🩸transfusion strategy had higher rates of death and MI at 30… https://t.co/goy7FnLSr4 https://t.co/slTNIjghYD
-
-
Mashup Score: 2ACC.24: FFR or Culprit-Only PCI in STEMI - 17 day(s) ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
NEW #ACC24 Featured CT Interview 💫Dr Felix Böhm discusses findings from a study investigating fractional flow reserve-guided complete or culprit-only #PCI in pts with #STEMI. 📽️👉 https://t.co/7aFoiziOLp 📊#FFR-guided complete non-culprit revascularization did not reduce… https://t.co/eiLzfeEqvw https://t.co/Jq5Jgu0vPD
-
-
Mashup Score: 1Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies - 21 day(s) ago
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited, and there are a multitude of associated conditions with overlapping symptoms which can make the diagnosis and management of POTS a difficult experience for providers and patients alike.
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1ACC.24: Periprocedural Cerebral Embolisms and Catheter Ablation of AF: The Embo-Abl Study - 24 day(s) ago
ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study.Embo-Abl is a multicenter prospective randomized
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
NEW #ACC24 Featured Science Interview 💫Dr Kengo Kusano discusses findings from the Embo-Abl study. 📽️👉 https://t.co/G4HXAiHAjO 📊Cryoballoon ablation was noninferior to radiofrequency ablation for the primary endpoint of MRI-detected silent cerebral event recurrence, 1-3 days… https://t.co/RwEoK5rts2 https://t.co/zylHirI5UK
-
-
Mashup Score: 2
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #ACC24 Interview 💫Dr @MoritzSeiffert joins us to discuss the findings of the DEDICATE-DZHK6 Trial. 📽️Watch here👉 https://t.co/CaJcGI8NPX 📊In pts with severe aortic stenosis at low or intermediate surgical risk, #TAVI with prosthesis selection based on operator… https://t.co/6m0C7tcHQr https://t.co/vXSWCBAdzD
-
-
Mashup Score: 1ACC.24: Technology-Assisted Nonprescription Rosuvastatin: TACTiC - 25 day(s) ago
ACC.24 — Investigator, Dr Steven Nissen joins us onsite to discuss the findings of a trial designed to evaluate the extent to which participants could safely and effectively select, purchase
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
NEW #ACC24 #LBCT Interview 💫Dr Steve Nissen joins us to discuss findings from the TACTiC trial evaluating #rosuvastatin calcium 5mg selection & use. 📽️Watch here👉 https://t.co/yCxVm73big 📊90.7% concordance between consumers and clinicians for initial self-selection 📊98.1%… https://t.co/M5UVMjbu2R https://t.co/etnEiXM6IX
-
-
Mashup Score: 11
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized,
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
NEW #ACC24 Late-Breaking Interview 💫Drs @rallamee and @MikeFoley89 discuss the ORBITA COSMIC trial. 📽️👉 https://t.co/9KaUCjlVZO 📊Coronary sinus reducer showed no improvement in transmural myocardial perfusion, but improved subendocardial perfusion, reduced angina frequency,… https://t.co/mKclhAfgbf https://t.co/7OOFYWWiKF
-
-
Mashup Score: 18ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT - 25 day(s) ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment
Source: www.uscjournal.comCategories: General Medicine News, Partners & KOLsTweet-
NEW #ACC24 Late Breaking Interview 💫Dr @akaplatini joins us to discuss findings from the PROACT trial. 📽️Watch here👉 https://t.co/NeDfhhvpQI 📊#Enalapril did not affect myocardial injury or cardiac function outcomes in patients treated for breast cancer and lymphoma.… https://t.co/pMApBNIczo https://t.co/FrWgrQal0p
-
🩺Attention cardiologists, neurologists and other HCPs! Join a panel of expert authors this week at our upcoming broadcast on Postural Orthostatic Tachycardia Syndrome and future care avenues. 📅 May 2, 15:30 BST/16:30 CEST Register today👉 https://t.co/qbZ6injubT #POTS #MedEd https://t.co/ePcaPf378O